Literature DB >> 14689054

Serum cytokine profile in the subclinical form of visceral leishmaniasis.

M E A Gama1, J M L Costa, J C R Pereira, C M C Gomes, C E P Corbett.   

Abstract

The factors determining the development or not of visceral leishmaniasis (VL) have not been completely identified, but a Leishmania-specific cellular immune response seems to play a fundamental role in the final control of infection. Few studies are available regarding the production of cytokines in the subclinical form of VL, with only the production of IFN-gamma and TNF-alpha known. The aim of the present study was to identify immunological markers for the oligosymptomatic or subclinical form of VL. A prospective cohort study was conducted on 784 children aged 0 to 5 years from an endemic area in the State of Maranhão, Brazil, between January 1998 and December 2001. During 30 consecutive months of follow-up, 33 children developed the oligosymptomatic form of the disease and 12 the acute form. During the clinical manifestations, serum cytokine levels were determined in 27 oligosymptomatic children and in nine patients with the acute form using a quantitative sandwich enzyme immunoassay. In the subclinical form of VL, variable levels of IL-2 were detected in 52.3% of the children, IL-12 in 85.2%, IFN-gamma in 48.1%, IL-10 in 88.9%, and TNF-alpha in 100.0%, with the last two cytokines showing significantly lower levels than in the acute form. IL-4 was not detected in oligosymptomatic individuals. Multiple discriminant analysis used to determine the profile or combination of cytokines predominating in the subclinical form revealed both a Leishmania resistance (Th1) and susceptibility (Th2) profile. The detection of both Th1 and Th2 cytokine profiles explains the self-limited evolution accompanied by the discrete alterations observed for the subclinical form of VL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689054     DOI: 10.1590/s0100-879x2004000100018

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  11 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses.

Authors:  Paulo Henrique da Costa Pinheiro; Suzana de Souza Dias; Kelsen Dantas Eulálio; Ivete L Mendonça; Simone Katz; Clara Lúcia Barbiéri
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 3.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

4.  Immunologic indicators of clinical progression during canine Leishmania infantum infection.

Authors:  Paola M Boggiatto; Amanda E Ramer-Tait; Kyle Metz; Erin E Kramer; Katherine Gibson-Corley; Kathleen Mullin; Jesse M Hostetter; Jack M Gallup; Douglas E Jones; Christine A Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

5.  Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.

Authors:  Arlene Caldas; Cecília Favali; Dorlene Aquino; Vera Vinhas; Johan van Weyenbergh; Cláudia Brodskyn; Jackson Costa; Manoel Barral-Netto; Aldina Barral
Journal:  BMC Infect Dis       Date:  2005-12-19       Impact factor: 3.090

6.  Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.

Authors:  Susanne Nylén; Radheshyam Maurya; Liv Eidsmo; Krishna Das Manandhar; Shyam Sundar; David Sacks
Journal:  J Exp Med       Date:  2007-03-26       Impact factor: 14.307

7.  Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.

Authors:  Guadalupe Andreani; Michel Ouellet; Rym Menasria; Alejandro Martin Gomez; Corinne Barat; Michel J Tremblay
Journal:  PLoS Negl Trop Dis       Date:  2015-02-24

8.  Dyarrheal Syndrome in a Patient Co-Infected with Leishmania infantum and Schistosoma mansoni.

Authors:  Gláucia Fernandes Cota; Luciana Inácia Gomes; Bruna Fernandes Pinto; Joanna R Santos-Oliveira; Alda Maria Da-Cruz; Moisés Salgado Pedrosa; Wagner Luiz Tafuri; Ana Rabello
Journal:  Case Rep Med       Date:  2012-11-18

Review 9.  A guide to modern statistical analysis of immunological data.

Authors:  Bernd Genser; Philip J Cooper; Maria Yazdanbakhsh; Mauricio L Barreto; Laura C Rodrigues
Journal:  BMC Immunol       Date:  2007-10-26       Impact factor: 3.615

10.  Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis.

Authors:  Alireza Ahmadi; Mehrdad Hajilooi; Ghasem Solgi; Mohammad Abasi; Ahad Bazmani; Mohammad Matini; Khosro Sardarian
Journal:  Adv Biomed Res       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.